How to streamline your clinical trial process to drive enrollment

One of the most critical steps in the clinical trial process is patient recruitment. Statistics show that approximately 80% of clinical trials are delayed or closed because of problems with recruitment. But without the right recruitment tools and strategies, clinical trial teams can’t find the volunteers that they need, ultimately slowing timelines. We outline three strategies to streamline your ...

Continue reading

How to find clinical trials near you

There are currently nearly 400,000 research studies listed on ClinicalTrials.gov in all 50 states (U.S.) and in 220 countries that need volunteers to take part. Even with so many options, it can be difficult for interested patients to find opportunities they're interested in near them. That’s why Antidote created a tool called Match, which allows patients to easily search for a trial based on a ...

Continue reading

What are the early warning signs of COPD?

COPD, also known as chronic obstructive pulmonary disease, is a condition that makes it hard to breathe and can worsen over time. Catching COPD early can help you better manage the disease, but symptoms can be mild, and you may even mistake them for a common cold. So, what are the early warning signs of COPD? 

Continue reading

7 clinical trial patient recruitment and retention tips

Clinical trials face some alarming statistics: 85% fail to recruit enough patients, 80% are delayed due to recruitment problems, and dropout rates soar. One way to fix this is by constructing a patient retention strategy that is engaging and provides clarity. Successful patient retention starts with patient-oriented clinical trial recruitment and giving potential volunteers the information they ...

Continue reading

Inclusivity in headache and migraine care and research

This is a reprint of an article originally published in the INvisible Project’s 5th edition of their Migraine and Headaches magazine, written by Antidote’s Head of Partnerships and Patient Advocacy, Lindsey Wahlstrom-Edwards. 

Continue reading

Stacey Kennedy-Conner’s lupus story

Stacey Kennedy-Conner was 15 years old when she was diagnosed with lupus. Through mentors at her high school, she was connected to lupus advocacy groups at a young age, and was introduced to the importance of building a sturdy support network. She has had lupus for almost 18 years now. She lives in Chicago, Illinois with her husband, professionally works in the school system supporting families ...

Continue reading

How patient lead generation can accelerate clinical trial patient recruitment [patient recruitment case study]

Postoperative Corneal Induced Chronic Pain (also known as CICP) is a condition that causes chronic pain and blurred vision after eye surgery. For the 300,000 people who experience this, effective treatments could drastically improve their quality of life. 

Continue reading

“Own Your Crohn’s”: Tina Aswani Omprakash talks to us about her IBD story

Tina Aswani Omprakash, a Crohn’s disease patient and advocate, helps empower the chronically ill and disabled. In fact, her site, “Own Your Crohn’s,” features her own experiences as well as the stories of IBD patients from around the world. We were lucky to have the opportunity to speak with Tina, where she told us about her Crohn’s disease diagnosis, how cultural stigma impacted her journey with ...

Continue reading

What types of clinical research are there?

Clinical trials are research studies that test if a new potential therapy is safe and effective for patients. They evaluate new drugs, devices, and sometimes behaviors, and reveal whether these potential therapies work for particular illnesses or particular groups of patients. Clinical trials provide the best available data with which to make healthcare decisions and are considered the gold ...

Continue reading

Clinical research in a post-COVID world: Four sites weigh in on the impact of COVID on the future of medical research [whitepaper]

Over the past year and a half, the traditional clinical research model of patient outreach, in-person screening, and site-based follow-up has had to adjust to drive progress while keeping patients safe. Now, with vaccines driving positivity rates down, we can begin to think about what’s next. Still, questions remain: Of all the changes made in the research industry since the beginning of the ...

Continue reading

Get our latest posts in your inbox.